Latham & Watkins has advised the lead managers on the offering. Linklaters advised Biocon Biologics. Biocon Biologics Plc, a wholly owned subsidiary of Biocon Biologics Limited...
Biocon Biologics’ $800 Million High Yield Bond Issuance
Biocon’s Share Sale in Syngene International
Cyril Amarchand Mangaldas advises Biocon on the deal. Biocon Limited (Biocon) executed the sale of shares of Syngene International Limited (Syngene International) by Biocon, with a reported...
Viatris’ $3.335 Billion Combination of Biosimilars Portfolio with Biocon Biologics
Cravath and Saraf and Partners represented Viatris in the transaction while Shardul Amarchand Mangaldas & Co and Goodwin Procter advised Biocon Biologics. Viatris Inc. reached a...
Serum Institute Life Sciences’ Acquisition of 15% Stake in Biocon Biologics
Shardul Amarchand Mangaldas & Co. and Krishnamurthy & Co. advised Biocon Biologics on the deal, while Veritas Legal advised Serum Institute Life Sciences. Biocon Biologics Limited...